Financial Performance - Revenue for Q3 2022 reached ¥2,552,798,330.49, an increase of 37.30% year-over-year[5] - Net profit attributable to shareholders was ¥512,506,689.39, up 33.82% compared to the same period last year[5] - Net profit excluding non-recurring gains and losses was ¥497,621,575.46, reflecting a 43.53% increase year-over-year[5] - Total operating revenue for the current period reached ¥7,112,888,300.79, a 28.7% increase from ¥5,528,395,699.44 in the previous period[18] - Net profit for the current period was ¥1,518,151,042.83, representing a 30.9% increase compared to ¥1,160,036,664.94 in the previous period[19] - Operating profit rose to ¥1,757,444,722.00, an increase of 32.0% from ¥1,331,285,698.89 in the previous period[19] - Basic and diluted earnings per share were both ¥1.20 for the current period[20] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥27,670,829,126.32, a 41.69% increase from the end of the previous year[5] - Total current assets increased to approximately CNY 21.08 billion from CNY 15.01 billion year-over-year, representing a growth of about 40.5%[15] - Total liabilities increased to CNY 10.22 billion from CNY 6.71 billion, representing a growth of about 52.5% year-over-year[17] - The company's total assets reached CNY 27.67 billion, up from CNY 19.53 billion, indicating a growth of approximately 41.7%[17] - The equity attributable to shareholders increased to CNY 16.62 billion from CNY 12.47 billion, reflecting a growth of about 33.5%[17] Cash Flow - Cash flow from operating activities for the year-to-date increased by 141.36% to ¥57,507,159.99[5] - Cash inflow from operating activities increased by 26.15% year-on-year, while cash outflow increased by 22.08%, leading to a net cash inflow increase of 141.36%[10] - Cash inflow from financing activities increased by 373.41% year-on-year, mainly due to funds raised from a private placement and IPO[10] - Total cash inflow from financing activities reached $4.92 billion, significantly higher than $1.04 billion in the previous period[22] - Net cash flow from financing activities was $3.17 billion, a turnaround from a negative cash flow of -$229.05 million in the previous period[22] - The ending balance of cash and cash equivalents was $2.70 billion, up from $2.20 billion in the previous period[22] Investments and Expenditures - The net cash flow from investment activities decreased by RMB 3.243 billion year-on-year, primarily due to increased capital expenditures and investments in new enterprises[10] - Cash outflow for the acquisition of fixed assets, intangible assets, and other long-term assets was $1.11 billion, up from $249.09 million in the previous period[22] - The company received $3.04 billion in cash from investments, including $552.33 million from minority shareholders[22] Other Financial Metrics - Operating costs increased by 33.37% year-on-year, primarily due to increased revenue scale and matching costs[10] - Financial expenses decreased by 679.88% year-on-year, mainly due to the appreciation of the US dollar and ruble, resulting in higher exchange gains[10] - Investment income increased by 96.88% year-on-year, attributed to higher earnings from joint ventures and foreign exchange swap business[10] - Other comprehensive income increased by 78.12%, primarily due to the impact of foreign currency translation differences[10] - Asset impairment losses increased by 227.41% year-on-year, mainly due to changes in the aging distribution of accounts receivable and long-term receivables[10] - Other income decreased by 42.76% year-on-year, primarily due to a reduction in government subsidies received in the current period[10] Strategic Initiatives - The company plans to accelerate its international strategy by issuing Global Depositary Receipts (GDR) and listing on the Swiss Stock Exchange, which was approved by the board on October 28, 2022[14] - As of October 11, 2022, the company completed the purchase of all stocks under the "Fighter 7" and "Partner 2" employee stock ownership plans, with a lock-up period of 12 months[14]